WEST PHARMACEUTICAL SERVICES, INC. Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) of $1.10 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-05.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised1 · last filed 2013-08-05
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $1.10M, a 266.67% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $2.60M, a 766.67% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $200.00K, a 100.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2012 was $4.90M, a 40.00% increase from fiscal 2011.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2011 was $3.50M, a 66.67% increase from fiscal 2010.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2010 was $2.10M.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $1.10M 10-Q · filed 2013-08-05 | $3.70M derived: sum of 3 quarters · filed 2013-08-05 | $3.90M derived: sum of 4 quarters · filed 2013-08-05 |
| 2013-03-31 | $1.10M 10-Q · filed 2013-05-06 | $3.70M derived: sum of 2 quarters · filed 2013-05-06 | $3.90M derived: sum of 3 quarters · filed 2013-05-06 | $5.70M derived: sum of 4 quarters · filed 2013-08-05 |
| 2012-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $2.80M derived: sum of 2 quarters · filed 2013-02-27 | $4.60M derived: sum of 3 quarters · filed 2013-08-05 | $4.90M 10-K · filed 2013-02-27 |
| 2012-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $2.00M derived: sum of 2 quarters · filed 2013-08-05 | $2.30M 10-Q · filed 2012-11-05 | $2.60M derived: sum of 4 quarters · filed 2013-08-05 |
| 2012-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $2.10M 10-Q · filed 2013-08-05 | $2.40M derived: sum of 3 quarters · filed 2013-08-05 | $2.50M derived: sum of 4 quarters · filed 2013-08-05 |
| 2012-03-31 | $300.00K 10-Q · filed 2013-05-06 | $600.00K derived: sum of 2 quarters · filed 2013-05-06 | $700.00K derived: sum of 3 quarters · filed 2013-05-06 | |
| 2011-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $400.00K derived: sum of 2 quarters · filed 2013-02-27 | $3.50M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $3.20M 10-Q · filed 2012-11-05 | ||
| 2011-06-30 | $3.10M 10-Q · filed 2012-08-06 | |||
| 2010-12-31 | $2.10M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |